Dare Bioscience Inc (DARE) — Cash Flow-to-Debt Ratio
Dare Bioscience Inc (DARE) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $1.44 Million could theoretically repay 0% of its total liabilities ($29.63 Million) in one year. Check Dare Bioscience Inc (DARE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dare Bioscience Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Dare Bioscience Inc across 15 annual periods. Also explore balance sheet size of Dare Bioscience Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dare Bioscience Inc (2011–2025)
Year-by-year debt coverage analysis for Dare Bioscience Inc. For market capitalisation and broader financial context, see DARE market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -333.62x | $-9.89 Billion | $29.63 Million | ▼ -173974.0% |
| 2024 | 0.19x | $5.39 Million | $28.11 Million | ▲ +113.0% |
| 2023 | -1.48x | $-38.86 Million | $26.33 Million | ▼ -166.9% |
| 2022 | -0.55x | $-18.09 Million | $32.71 Million | ▲ +67.2% |
| 2021 | -1.69x | $-28.76 Million | $17.05 Million | ▲ +41.8% |
| 2020 | -2.90x | $-25.23 Million | $8.70 Million | ▼ -52.5% |
| 2019 | -1.90x | $-13.32 Million | $7.00 Million | ▲ +79.6% |
| 2018 | -9.33x | $-10.27 Million | $1.10 Million | ▼ -255.1% |
| 2017 | -2.63x | $-2.54 Million | $967.04K | ▼ -92.5% |
| 2016 | -1.36x | $-33.54 Million | $24.58 Million | ▼ -26.1% |
| 2015 | -1.08x | $-31.91 Million | $29.48 Million | ▲ +54.2% |
| 2014 | -2.36x | $-19.06 Million | $8.07 Million | ▼ -36.7% |
| 2013 | -1.73x | $-16.61 Million | $9.62 Million | ▼ -703.7% |
| 2012 | -0.21x | $-21.00 Million | $97.70 Million | ▲ +94.5% |
| 2011 | -3.89x | $-16.88 Million | $4.34 Million | — |